title: Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.
abstract: Employers may be loath to fund vaccination programs without understanding the economic consequences. We developed a decision analytic computational simulation model including dynamic transmission elements that estimated the cost-benefit of employer-sponsored workplace vaccination from the employer's perspective. Implementing such programs was relatively inexpensive (<$35/vaccinated employee) and, in many cases, cost saving across diverse occupational groups in all seasonal influenza scenarios. Such programs were cost-saving for a 20% serologic attack rate pandemic scenario (range: -$15 to -$995) per vaccinated employee) and a 30% serologic attack rate pandemic scenario (range: -$39 to -$1,494 per vaccinated employee) across all age and major occupational groups.
authors.affiliation: Applied Modeling, Public Health Computational and Operations Research, University of Pittsburgh, Pittsburgh, PA 15213, USA. BYL1@pitt.edu
authors.forename: Bruce Y
authors.initials: BY
authors.lastname: Lee
authors.forename: Rachel R
authors.initials: RR
authors.lastname: Bailey
authors.forename: Ann E
authors.initials: AE
authors.lastname: Wiringa
authors.forename: Abena
authors.initials: A
authors.lastname: Afriyie
authors.forename: Angela R
authors.initials: AR
authors.lastname: Wateska
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Smith
authors.forename: Richard K
authors.initials: RK
authors.lastname: Zimmerman
mesh_terms: D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D003657:Decision Making; D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D007252:Influenza Vaccines / Q000191:economics*; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D018803:Models, Economic; D014611:Vaccination / Q000191:economics*; D017132:Workplace
chemical_list: D007252:Influenza Vaccines